Geneos Wealth Management’s Templeton Emerging Markets Fund EMF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
– Sell
-500
Closed -$6K – 2427
2018
Q4
$6K Hold
500
– – ﹤0.01% 1918
2018
Q3
$7K Hold
500
– – ﹤0.01% 1955
2018
Q2
$7K Hold
500
– – ﹤0.01% 1820
2018
Q1
$8K Hold
500
– – ﹤0.01% 1712
2017
Q4
$8K Hold
500
– – ﹤0.01% 1696
2017
Q3
$8K Sell
500
-100
-17% -$1.61K ﹤0.01% 1634
2017
Q2
$8K Hold
600
– – ﹤0.01% 1594
2017
Q1
$8K Buy
600
+100
+20% +$1.32K ﹤0.01% 1551
2016
Q4
$6K Hold
500
– – ﹤0.01% 1568
2016
Q3
$6K Hold
500
– – ﹤0.01% 1506
2016
Q2
$5K Hold
500
– – ﹤0.01% 1507
2016
Q1
$5K Buy
+500
New +$4.86K ﹤0.01% 1472

Other funds holding EMF

Geneos Wealth Management's EMF Position: Q1 2019 in Review

Geneos Wealth Management sold out of Templeton Emerging Markets Fund (EMF) in Q1 2019, closing a stake of 500 shares — an estimated $6K sold.

Geneos Wealth Management first reported a position in EMF in Q1 2016 and held it in 12 quarters. The position peaked at $8K in Q1 2018. 43 funds tracked by Wall St. Rank hold EMF as of Q1 2019.

  • Geneos Wealth Management reported no remaining Templeton Emerging Markets Fund position as of Q1 2019 after selling out during the quarter.
  • Geneos Wealth Management sold 500 Templeton Emerging Markets Fund shares in Q1 2019, an estimated $6K.
  • Geneos Wealth Management first reported a position in Templeton Emerging Markets Fund in Q1 2016 and held it in 12 quarters.
  • Geneos Wealth Management's Templeton Emerging Markets Fund position peaked at $8K in Q1 2018.
  • 43 funds tracked by Wall St. Rank held Templeton Emerging Markets Fund as of Q1 2019.

Based on Geneos Wealth Management's 13F filing for Q1 2019, filed 7 Sep 2021.